Impact of Laparoscopic Sclerotherapy for Ovarian Endometriomas on Ovarian Reserve
Objective: To evaluate the impact of laparoscopic sclerotherapy on the management of endometrioma during surgery for deep infiltrative endometriosis (DIE). Observational study. Tivoli-Ducos Clinic, Bordeaux. Sixty-nine patients underwent laparoscopic sclerotherapy for endometrioma during surgery for...
Gespeichert in:
| Veröffentlicht in: | Journal of minimally invasive gynecology 2023-01, Vol.30 (1), p.32-38 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 38 |
|---|---|
| container_issue | 1 |
| container_start_page | 32 |
| container_title | Journal of minimally invasive gynecology |
| container_volume | 30 |
| creator | Crestani, Adrien Merlot, Benjamin Dennis, Thomas Chanavaz-Lacheray, Isabella Roman, Horace |
| description | Objective: To evaluate the impact of laparoscopic sclerotherapy on the management of endometrioma during surgery for deep infiltrative endometriosis (DIE).
Observational study.
Tivoli-Ducos Clinic, Bordeaux.
Sixty-nine patients underwent laparoscopic sclerotherapy for endometrioma during surgery for DIE.
Laparoscopic sclerotherapy with 95% ethanol solution and DIE surgery.
Antimüllerian hormone (AMH) levels before and at least 6 months after surgery, recurrences, and pregnancies. Mean AMH (ng/mL) levels were 3.4 (2.3) before surgery and 2 (1.7) after surgery (p 40 mm during surgery for DIE sclerotherapy has a low impact on AMH, preserves fertility, and prevents recurrence. |
| doi_str_mv | 10.1016/j.jmig.2022.10.001 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2725192556</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1553465022009438</els_id><sourcerecordid>2725192556</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e1f63e8d1c1abb8bb3fc4bbe35079db6590b6668db58940bea14aa8e19dd521f3</originalsourceid><addsrcrecordid>eNp9kEtLw0AUhQdRbK3-AReSpZvGeWSmCbgRqVooFF_rYR43OiHJxJm00H9vSmuXru7l3nMOnA-ha4JTgom4q9KqcV8pxZQOhxRjcoLGhHM2zYQoTo87xyN0EWOFMZthLM7RiAlK81ywMXpdNJ0yfeLLZKk6FXw0vnMmeTc1BN9_Q1DdNil9SFYbFZxqk3lrfQN9cL5RMfHt8fEGEcIGLtFZqeoIV4c5QZ9P84_Hl-ly9bx4fFhODeOinwIpBYPcEkOU1rnWrDSZ1sA4nhVWC15gLYTIreZ5kWENimRK5UAKazklJZug231uF_zPGmIvGxcN1LVqwa-jpDPKSUE5F4OU7qVm6BcDlLILrlFhKwmWO5SykjuUcodydxtQDqabQ_5aN2CPlj92g-B-L4Ch5cZBkNE4aA1YF8D00nr3X_4vLlaGEA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2725192556</pqid></control><display><type>article</type><title>Impact of Laparoscopic Sclerotherapy for Ovarian Endometriomas on Ovarian Reserve</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Crestani, Adrien ; Merlot, Benjamin ; Dennis, Thomas ; Chanavaz-Lacheray, Isabella ; Roman, Horace</creator><creatorcontrib>Crestani, Adrien ; Merlot, Benjamin ; Dennis, Thomas ; Chanavaz-Lacheray, Isabella ; Roman, Horace</creatorcontrib><description>Objective: To evaluate the impact of laparoscopic sclerotherapy on the management of endometrioma during surgery for deep infiltrative endometriosis (DIE).
Observational study.
Tivoli-Ducos Clinic, Bordeaux.
Sixty-nine patients underwent laparoscopic sclerotherapy for endometrioma during surgery for DIE.
Laparoscopic sclerotherapy with 95% ethanol solution and DIE surgery.
Antimüllerian hormone (AMH) levels before and at least 6 months after surgery, recurrences, and pregnancies. Mean AMH (ng/mL) levels were 3.4 (2.3) before surgery and 2 (1.7) after surgery (p <.001). Mean difference was 1.29 ng/mL. Preoperative AMH level was the only variable independently associated with an additive decrease in AMH. Mean (standard deviation) follow-up period was 17.5 months (4.6) (range 9–26 months); 18 of 44 patients (40.1%) with pregnancy intent conceived. Of 51 patients who underwent postoperative pelvic ultrasound, 6 (6 of 51, 11.8%) had a recurrence of endometrioma.
Laparoscopic sclerotherapy for endometrioma >40 mm during surgery for DIE sclerotherapy has a low impact on AMH, preserves fertility, and prevents recurrence.</description><identifier>ISSN: 1553-4650</identifier><identifier>EISSN: 1553-4669</identifier><identifier>DOI: 10.1016/j.jmig.2022.10.001</identifier><identifier>PMID: 36228863</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anti-Mullerian Hormone ; DIE ; Endometrioma ; Endometriosis - surgery ; Female ; Fertility ; Humans ; Laparoscopic sclerotherapy ; Laparoscopy ; Ovarian Reserve ; Pregnancy ; Prospective Studies ; Sclerotherapy</subject><ispartof>Journal of minimally invasive gynecology, 2023-01, Vol.30 (1), p.32-38</ispartof><rights>2022 AAGL</rights><rights>Copyright © 2022 AAGL. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e1f63e8d1c1abb8bb3fc4bbe35079db6590b6668db58940bea14aa8e19dd521f3</citedby><cites>FETCH-LOGICAL-c356t-e1f63e8d1c1abb8bb3fc4bbe35079db6590b6668db58940bea14aa8e19dd521f3</cites><orcidid>0000-0002-7826-6656</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1553465022009438$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36228863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Crestani, Adrien</creatorcontrib><creatorcontrib>Merlot, Benjamin</creatorcontrib><creatorcontrib>Dennis, Thomas</creatorcontrib><creatorcontrib>Chanavaz-Lacheray, Isabella</creatorcontrib><creatorcontrib>Roman, Horace</creatorcontrib><title>Impact of Laparoscopic Sclerotherapy for Ovarian Endometriomas on Ovarian Reserve</title><title>Journal of minimally invasive gynecology</title><addtitle>J Minim Invasive Gynecol</addtitle><description>Objective: To evaluate the impact of laparoscopic sclerotherapy on the management of endometrioma during surgery for deep infiltrative endometriosis (DIE).
Observational study.
Tivoli-Ducos Clinic, Bordeaux.
Sixty-nine patients underwent laparoscopic sclerotherapy for endometrioma during surgery for DIE.
Laparoscopic sclerotherapy with 95% ethanol solution and DIE surgery.
Antimüllerian hormone (AMH) levels before and at least 6 months after surgery, recurrences, and pregnancies. Mean AMH (ng/mL) levels were 3.4 (2.3) before surgery and 2 (1.7) after surgery (p <.001). Mean difference was 1.29 ng/mL. Preoperative AMH level was the only variable independently associated with an additive decrease in AMH. Mean (standard deviation) follow-up period was 17.5 months (4.6) (range 9–26 months); 18 of 44 patients (40.1%) with pregnancy intent conceived. Of 51 patients who underwent postoperative pelvic ultrasound, 6 (6 of 51, 11.8%) had a recurrence of endometrioma.
Laparoscopic sclerotherapy for endometrioma >40 mm during surgery for DIE sclerotherapy has a low impact on AMH, preserves fertility, and prevents recurrence.</description><subject>Anti-Mullerian Hormone</subject><subject>DIE</subject><subject>Endometrioma</subject><subject>Endometriosis - surgery</subject><subject>Female</subject><subject>Fertility</subject><subject>Humans</subject><subject>Laparoscopic sclerotherapy</subject><subject>Laparoscopy</subject><subject>Ovarian Reserve</subject><subject>Pregnancy</subject><subject>Prospective Studies</subject><subject>Sclerotherapy</subject><issn>1553-4650</issn><issn>1553-4669</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLw0AUhQdRbK3-AReSpZvGeWSmCbgRqVooFF_rYR43OiHJxJm00H9vSmuXru7l3nMOnA-ha4JTgom4q9KqcV8pxZQOhxRjcoLGhHM2zYQoTo87xyN0EWOFMZthLM7RiAlK81ywMXpdNJ0yfeLLZKk6FXw0vnMmeTc1BN9_Q1DdNil9SFYbFZxqk3lrfQN9cL5RMfHt8fEGEcIGLtFZqeoIV4c5QZ9P84_Hl-ly9bx4fFhODeOinwIpBYPcEkOU1rnWrDSZ1sA4nhVWC15gLYTIreZ5kWENimRK5UAKazklJZug231uF_zPGmIvGxcN1LVqwa-jpDPKSUE5F4OU7qVm6BcDlLILrlFhKwmWO5SykjuUcodydxtQDqabQ_5aN2CPlj92g-B-L4Ch5cZBkNE4aA1YF8D00nr3X_4vLlaGEA</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>Crestani, Adrien</creator><creator>Merlot, Benjamin</creator><creator>Dennis, Thomas</creator><creator>Chanavaz-Lacheray, Isabella</creator><creator>Roman, Horace</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7826-6656</orcidid></search><sort><creationdate>202301</creationdate><title>Impact of Laparoscopic Sclerotherapy for Ovarian Endometriomas on Ovarian Reserve</title><author>Crestani, Adrien ; Merlot, Benjamin ; Dennis, Thomas ; Chanavaz-Lacheray, Isabella ; Roman, Horace</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e1f63e8d1c1abb8bb3fc4bbe35079db6590b6668db58940bea14aa8e19dd521f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anti-Mullerian Hormone</topic><topic>DIE</topic><topic>Endometrioma</topic><topic>Endometriosis - surgery</topic><topic>Female</topic><topic>Fertility</topic><topic>Humans</topic><topic>Laparoscopic sclerotherapy</topic><topic>Laparoscopy</topic><topic>Ovarian Reserve</topic><topic>Pregnancy</topic><topic>Prospective Studies</topic><topic>Sclerotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crestani, Adrien</creatorcontrib><creatorcontrib>Merlot, Benjamin</creatorcontrib><creatorcontrib>Dennis, Thomas</creatorcontrib><creatorcontrib>Chanavaz-Lacheray, Isabella</creatorcontrib><creatorcontrib>Roman, Horace</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of minimally invasive gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crestani, Adrien</au><au>Merlot, Benjamin</au><au>Dennis, Thomas</au><au>Chanavaz-Lacheray, Isabella</au><au>Roman, Horace</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Laparoscopic Sclerotherapy for Ovarian Endometriomas on Ovarian Reserve</atitle><jtitle>Journal of minimally invasive gynecology</jtitle><addtitle>J Minim Invasive Gynecol</addtitle><date>2023-01</date><risdate>2023</risdate><volume>30</volume><issue>1</issue><spage>32</spage><epage>38</epage><pages>32-38</pages><issn>1553-4650</issn><eissn>1553-4669</eissn><abstract>Objective: To evaluate the impact of laparoscopic sclerotherapy on the management of endometrioma during surgery for deep infiltrative endometriosis (DIE).
Observational study.
Tivoli-Ducos Clinic, Bordeaux.
Sixty-nine patients underwent laparoscopic sclerotherapy for endometrioma during surgery for DIE.
Laparoscopic sclerotherapy with 95% ethanol solution and DIE surgery.
Antimüllerian hormone (AMH) levels before and at least 6 months after surgery, recurrences, and pregnancies. Mean AMH (ng/mL) levels were 3.4 (2.3) before surgery and 2 (1.7) after surgery (p <.001). Mean difference was 1.29 ng/mL. Preoperative AMH level was the only variable independently associated with an additive decrease in AMH. Mean (standard deviation) follow-up period was 17.5 months (4.6) (range 9–26 months); 18 of 44 patients (40.1%) with pregnancy intent conceived. Of 51 patients who underwent postoperative pelvic ultrasound, 6 (6 of 51, 11.8%) had a recurrence of endometrioma.
Laparoscopic sclerotherapy for endometrioma >40 mm during surgery for DIE sclerotherapy has a low impact on AMH, preserves fertility, and prevents recurrence.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36228863</pmid><doi>10.1016/j.jmig.2022.10.001</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7826-6656</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1553-4650 |
| ispartof | Journal of minimally invasive gynecology, 2023-01, Vol.30 (1), p.32-38 |
| issn | 1553-4650 1553-4669 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2725192556 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Anti-Mullerian Hormone DIE Endometrioma Endometriosis - surgery Female Fertility Humans Laparoscopic sclerotherapy Laparoscopy Ovarian Reserve Pregnancy Prospective Studies Sclerotherapy |
| title | Impact of Laparoscopic Sclerotherapy for Ovarian Endometriomas on Ovarian Reserve |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T12%3A44%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Laparoscopic%20Sclerotherapy%20for%20Ovarian%20Endometriomas%20on%20Ovarian%20Reserve&rft.jtitle=Journal%20of%20minimally%20invasive%20gynecology&rft.au=Crestani,%20Adrien&rft.date=2023-01&rft.volume=30&rft.issue=1&rft.spage=32&rft.epage=38&rft.pages=32-38&rft.issn=1553-4650&rft.eissn=1553-4669&rft_id=info:doi/10.1016/j.jmig.2022.10.001&rft_dat=%3Cproquest_cross%3E2725192556%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2725192556&rft_id=info:pmid/36228863&rft_els_id=S1553465022009438&rfr_iscdi=true |